LeonaBio (LONA) Current Assets (2019 - 2026)

LeonaBio (LONA) has 8 years of Current Assets data on file, last reported at $69.2 million in Q1 2026.

• Quarterly Current Assets rose 73.64% year-over-year to $69.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69.2 million (up 73.64% YoY) and the FY2025 annual result came in at $89.5 million, up 63.12% from the prior year.
• Current Assets retreated to $69.2 million in Q1 2026 per LONA's latest filing, from $89.5 million in the prior quarter.
• Across five years, Current Assets topped out at $269.2 million in Q1 2022 and bottomed at $27.0 million in Q3 2025.
• The 5-year median for Current Assets is $128.6 million (2024), against an average of $135.9 million.
• The widest annual swing landed in 2025, when Current Assets plunged 69.81%; it then surged 73.64% in 2026.
• Tracing LONA's Current Assets over 5 years: stood at $207.5 million in 2022, then decreased by 25.44% to $154.7 million in 2023, then tumbled by 64.56% to $54.8 million in 2024, then soared by 63.12% to $89.5 million in 2025, then slipped by 22.64% to $69.2 million in 2026.
• Per Business Quant, the three latest LONA Current Assets figures stand at $69.2 million (Q1 2026), $89.5 million (Q4 2025), and $27.0 million (Q3 2025).

Peer Comparison